Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways

Abstract: Background: Chronic immune-mediated inflammation remains difficult to treat with single-target approaches. Terpenoids are known to modulate immune responses, but whether specific combinations can produce enhanced effects and through which mechanisms is not well understood. Objectives: This study investigates whether a fixed-ratio combination (5:23:26) of (-)-Linalool, (-)-Borneol and β-Caryophyllene (Formula 1) exerts enhanced anti-inflammatory effects and explores the underlying molecular mechanisms. Methods: Two complementary models were used: release of slow-reacting substance of anaphylaxis (SRS-A) in isolated guinea pig ileum and LPS-activated RAW264.7 macrophages. PGE2, LTB4, NO and iNOS levels were measured. Network pharmacology, followed by experimental validation, identified key targets and pathways. Cellular morphology, apoptosis and NF-κB p65 nuclear accumulation were assessed by Hoechst 33342/PI staining and fluorescent plasmid transfection. Results: Formula 1 achieved 79.88% inhibition of SRS-A release, significantly surpassing every single component (P < 0.001) and the positive control quercetin. It also reduced PGE2, LTB4, NO and iNOS levels more effectively than any single compound. In LPS-stimulated macrophages, Formula 1 reduced cell deformation and apoptosis and markedly reduced p65 nuclear translocation. Mechanistically, it increased the Nrf2/HO-1 axis while down-regulating NF-κB and the arachidonic acid pathway. Notably, even when (-)-Linalool was reduced to one-tenth of its dose, Formula 1 maintained comparable efficacy. Conclusions: The combination of (-)-Linalool, (-)-Borneol and β-Caryophyllene produces enhanced anti-inflammatory effects through coordinated regulation of multiple pathways, as supported by the Highest Single Agent (HSA) model. These findings provide a basis for developing multi-target therapies for immune-mediated inflammatory diseases

Authors

Institutions

Publication Details

Journal
Pakistan Journal of Pharmaceutical Sciences
Published
2026-11-12
DOI
https://doi.org/10.36721/pjps/2026.40.16377.1
Primary Topic
Natural Compounds in Disease Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways

WanLin Wang
Pakistan Journal of Pharmaceutical Sciences
Natural Compounds in Disease Treatment
article

Enhanced anti-inflammatory effects of (-)-linalool, (-)-borneol and β-caryophyllene via NF-κB/Nrf2 and arachidonic acid pathways

WanLin Wang
article en

Abstract

Abstract: Background: Chronic immune-mediated inflammation remains difficult to treat with single-target approaches. Terpenoids are known to modulate immune responses, but whether specific combinations can produce enhanced effects and through which mechanisms is not well understood. Objectives: This study investigates whether a fixed-ratio combination (5:23:26) of (-)-Linalool, (-)-Borneol and β-Caryophyllene (Formula 1) exerts enhanced anti-inflammatory effects and explores the underlying molecular mechanisms. Methods: Two complementary models were used: release of slow-reacting substance of anaphylaxis (SRS-A) in isolated guinea pig ileum and LPS-activated RAW264.7 macrophages. PGE2, LTB4, NO and iNOS levels were measured. Network pharmacology, followed by experimental validation, identified key targets and pathways. Cellular morphology, apoptosis and NF-κB p65 nuclear accumulation were assessed by Hoechst 33342/PI staining and fluorescent plasmid transfection. Results: Formula 1 achieved 79.88% inhibition of SRS-A release, significantly surpassing every single component (P < 0.001) and the positive control quercetin. It also reduced PGE2, LTB4, NO and iNOS levels more effectively than any single compound. In LPS-stimulated macrophages, Formula 1 reduced cell deformation and apoptosis and markedly reduced p65 nuclear translocation. Mechanistically, it increased the Nrf2/HO-1 axis while down-regulating NF-κB and the arachidonic acid pathway. Notably, even when (-)-Linalool was reduced to one-tenth of its dose, Formula 1 maintained comparable efficacy. Conclusions: The combination of (-)-Linalool, (-)-Borneol and β-Caryophyllene produces enhanced anti-inflammatory effects through coordinated regulation of multiple pathways, as supported by the Highest Single Agent (HSA) model. These findings provide a basis for developing multi-target therapies for immune-mediated inflammatory diseases

Pakistan Journal of Pharmaceutical Sciences
Guizhou University (CN)
National Research Foundation, National Natural Science Foundation of China
Good health and well-being
Natural Compounds in Disease Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon